Sequenciação Terapêutica em Mieloma Múltiplo
Lista de alterações
Ação | Autor | Revisor | Data | Hora |
---|---|---|---|---|
Criação | Prof.ª Catarina Geraldes | Dr. Manuel Neves | 01/05/2023 | 00:00 |
Bibliografia | ||||
1. Dimopoulos MA et al. Lancet Oncol 2016;17:27–38; 2. Mateos M et al. ASCO 2018 #8000; 3 3. Palumbo A et al. NEJM 2016;375:754–66; 4. Spencer A et al. ASH 2017 #3145; 5. Usmani SZ et al. ASH 2019; 6. Usmani S et al. Lancet Oncol 2022;23(1):65-76; 7. Chari A et al. Blood 2019; doi:10.1182/blood.2019000722; 8. Moreau P et al. EHA 2020 LB2603; 9. Moreau P et al COMY 2022, Sanofi Press release 15 May 2022; 10. Richardson PG et al. ASCO 2018 #8001; 11. Richardson PG et al. EHA 2018 #S847; 12. Dimopoulos M et al. N Engl J Med 2018;379:1811-22; 13. Dimopoulos M et al. EHA 2018; Abstract LB2606; 14. Attal M et al. Lancet 2019;394:2096-107; 15. Dimopoulos MA et al. Lancet Oncol 2021;22:801-812; 16. Mateos M-V, et al. Presented at 62nd ASH Annual Meeting and Exposition; Dec 5–8, 2020; Virtual. Abstract 415 (Oral); 17. Puertas B et al. Presented at IMS 2022; Abstract 050 (Oral). 18. Dimopoulos M et al. Ann Oncol 2021; 32:309-322
|